CA3041253A1 - Validation of continuous viral clearance - Google Patents
Validation of continuous viral clearance Download PDFInfo
- Publication number
- CA3041253A1 CA3041253A1 CA3041253A CA3041253A CA3041253A1 CA 3041253 A1 CA3041253 A1 CA 3041253A1 CA 3041253 A CA3041253 A CA 3041253A CA 3041253 A CA3041253 A CA 3041253A CA 3041253 A1 CA3041253 A1 CA 3041253A1
- Authority
- CA
- Canada
- Prior art keywords
- sampling
- viral
- probe
- cfi
- continuous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/22—Testing for sterility conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
- A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
- A61L2/08—Radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
- A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2103/00—Materials or objects being the target of disinfection or sterilisation
- A61L2103/05—Living organisms or biological materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16194959.9 | 2016-10-21 | ||
| EP16194959.9A EP3141611A3 (en) | 2016-10-21 | 2016-10-21 | Validation of continuous viral clearance |
| PCT/US2017/057298 WO2018075716A1 (en) | 2016-10-21 | 2017-10-19 | Validation of continuous viral clearance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3041253A1 true CA3041253A1 (en) | 2018-04-26 |
Family
ID=57209212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3041253A Abandoned CA3041253A1 (en) | 2016-10-21 | 2017-10-19 | Validation of continuous viral clearance |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10894991B2 (enExample) |
| EP (2) | EP3141611A3 (enExample) |
| JP (1) | JP2019537435A (enExample) |
| KR (1) | KR20190066017A (enExample) |
| CN (1) | CN110100008A (enExample) |
| AR (1) | AR109846A1 (enExample) |
| AU (1) | AU2017345412A1 (enExample) |
| BR (1) | BR112019007835A2 (enExample) |
| CA (1) | CA3041253A1 (enExample) |
| IL (1) | IL266095A (enExample) |
| MX (1) | MX385466B (enExample) |
| RU (1) | RU2755634C2 (enExample) |
| SG (1) | SG10202104023QA (enExample) |
| TW (1) | TW201827830A (enExample) |
| UY (1) | UY37447A (enExample) |
| WO (1) | WO2018075716A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190022654A1 (en) * | 2017-07-10 | 2019-01-24 | Baxalta Incorporated | Method for incubating liquids |
| EP4112735A4 (en) * | 2020-02-28 | 2023-09-06 | Asahi Kasei Medical Co., Ltd. | METHOD FOR EVALUATING VIRAL CLEARANCE PERFORMANCE |
| WO2022060535A1 (en) * | 2020-09-21 | 2022-03-24 | Bayer Healthcare Llc | Pathogen clearance system and method |
| US12203914B2 (en) * | 2020-11-12 | 2025-01-21 | Sartorius Bioanalytical Instruments, Inc. | Viral clearance evaluation for biological medical product preparation processes |
| WO2022203044A1 (ja) * | 2021-03-26 | 2022-09-29 | 旭化成メディカル株式会社 | ウイルスクリアランス試験の方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG184833A1 (en) * | 2010-04-14 | 2012-11-29 | Emd Millipore Corp | Methods of producing high titer, high purity virus stocks and methods of use thereof |
| AU2014100888A4 (en) * | 2014-08-07 | 2014-09-11 | Novartis Ag | Virus clearance and protein purification methods |
-
2016
- 2016-10-21 EP EP16194959.9A patent/EP3141611A3/en not_active Withdrawn
-
2017
- 2017-10-19 BR BR112019007835-5A patent/BR112019007835A2/pt not_active IP Right Cessation
- 2017-10-19 TW TW106135849A patent/TW201827830A/zh unknown
- 2017-10-19 AU AU2017345412A patent/AU2017345412A1/en not_active Abandoned
- 2017-10-19 CA CA3041253A patent/CA3041253A1/en not_active Abandoned
- 2017-10-19 KR KR1020197010823A patent/KR20190066017A/ko not_active Ceased
- 2017-10-19 RU RU2019115375A patent/RU2755634C2/ru active
- 2017-10-19 JP JP2019520956A patent/JP2019537435A/ja not_active Ceased
- 2017-10-19 MX MX2019004540A patent/MX385466B/es unknown
- 2017-10-19 WO PCT/US2017/057298 patent/WO2018075716A1/en not_active Ceased
- 2017-10-19 EP EP17791896.8A patent/EP3529367A1/en not_active Withdrawn
- 2017-10-19 SG SG10202104023QA patent/SG10202104023QA/en unknown
- 2017-10-19 CN CN201780064932.4A patent/CN110100008A/zh active Pending
- 2017-10-20 UY UY0001037447A patent/UY37447A/es not_active Application Discontinuation
- 2017-10-20 AR ARP170102921A patent/AR109846A1/es not_active Application Discontinuation
- 2017-10-20 US US16/343,125 patent/US10894991B2/en not_active Expired - Fee Related
-
2019
- 2019-04-17 IL IL266095A patent/IL266095A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20190316213A1 (en) | 2019-10-17 |
| IL266095A (en) | 2019-06-30 |
| EP3529367A1 (en) | 2019-08-28 |
| SG10202104023QA (en) | 2021-06-29 |
| EP3141611A2 (en) | 2017-03-15 |
| TW201827830A (zh) | 2018-08-01 |
| WO2018075716A1 (en) | 2018-04-26 |
| BR112019007835A2 (pt) | 2019-10-01 |
| RU2019115375A3 (enExample) | 2021-03-19 |
| UY37447A (es) | 2018-05-31 |
| US10894991B2 (en) | 2021-01-19 |
| EP3141611A3 (en) | 2017-05-10 |
| AR109846A1 (es) | 2019-01-30 |
| JP2019537435A (ja) | 2019-12-26 |
| MX385466B (es) | 2025-03-18 |
| CN110100008A (zh) | 2019-08-06 |
| AU2017345412A1 (en) | 2019-04-18 |
| RU2755634C2 (ru) | 2021-09-17 |
| MX2019004540A (es) | 2019-06-12 |
| KR20190066017A (ko) | 2019-06-12 |
| RU2019115375A (ru) | 2020-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10894991B2 (en) | Validation of continuous viral clearance | |
| Gillespie et al. | Continuous in‐line virus inactivation for next generation bioprocessing | |
| ES2895173T3 (es) | Métodos para inactivar virus durante un proceso de purificación de proteínas | |
| Suba et al. | Capillary isoelectric focusing method development and validation for investigation of recombinant therapeutic monoclonal antibody | |
| CN104049025A (zh) | 微量注射泵驱动液流的毛细管电泳分析系统 | |
| von der Au et al. | Development of an automated on-line purification HPLC single cell-ICP-MS approach for fast diatom analysis | |
| TWI686471B (zh) | 流體通道及連續流動系統中保持窄滯留時間分布的機械方法 | |
| TWI698529B (zh) | 連續流動系統中保持窄滯留時間分布的方法 | |
| JP7173671B2 (ja) | クロマトグラフィーのための質量制御システム | |
| JP2020526210A (ja) | 液体をインキュベートおよびウイルスを不活化するための方法 | |
| JP2010537197A (ja) | 液体クロマトグラフィー溶離液を排流するためのシステム及び方法 | |
| US20190359930A1 (en) | Method for sampling fluid streams for monitoring contaminants in a continuous flow | |
| CN105241973A (zh) | 蛋白制剂的高效液相色谱检测方法 | |
| He et al. | Multiresidue determination of (fluoro) quinolone antibiotics in chicken by polymer monolith microextraction and field-amplified sample stacking procedures coupled to CE-UV | |
| CN105301127B (zh) | 一种利巴韦林药物组合物及其有关物质检测方法 | |
| CN107024554A (zh) | 一种血清中全氟化合物的检测装置 | |
| HK40011645A (zh) | 连续病毒清除的验证 | |
| CN114460219A (zh) | 分离病毒载体的方法 | |
| JP2013253888A (ja) | 質量分析を用いた定量分析方法と定量分析装置 | |
| CN115343402B (zh) | 游离睾酮的检测方法 | |
| AU2016221726B2 (en) | Method for quantification of virus particles using capillary zone electrophoresis | |
| CN107991412A (zh) | 高效液相色谱法测定阿哌沙班杂质含量的方法 | |
| Nissankararao et al. | Dissolution method development and validation: a review | |
| CN108627590A (zh) | 一种测定依地酸二钠含量的高效液相色谱分析方法 | |
| CN109387581B (zh) | 一种口蹄疫抗原的定量方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20240130 |